TITLE

GVK, DuPont expands alliance

PUB. DATE
March 2009
SOURCE
Chemical Business;Mar2009, Vol. 23 Issue 3, p63
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces that the research organization, GVK Biosciences, was appointed as a partner by DuPont Crop Protection for discovery Chemistry services in India. It says that the 5-year relation between the two companies have already established a Chemistry team that will work on DuPont's research and development initiatives.
ACCESSION #
37803940

 

Related Articles

  • Indian drug discovery company seals international partnership.  // Pharmaceutical Technology Asia;Apr2002, p4 

    Reports on a partnership between drug development companies Ricerca LLC and gvk bioSciences to build a medical research and development facility at the ICICI Knowledge Park in Hyderabad, India. Purpose of the facility; Significance of the partnership to the growth of gvk bioSciences; Terms of...

  • Ricerca Forms Alliance with Siegfried and Gvk BioScience. Mullin, Rick // Chemical Week;3/6/2002, Vol. 164 Issue 10, p33 

    Highlights the alliance formed by drug development company Ricerca with Siegfried to collaborate on active pharmaceutical ingredient development and manufacturing projects for the drug industry. Services which will be provided by Ricerca for the development program; Information on the...

  • GVK Bio under scanner of European drug regulator.  // FRPT- Chemical Snapshot;10/19/2014, p25 

    The article reports on the review conducted by the European Medicines Agency (EMA) in connection to the alleged non-compliance with good clinical practice (GCP) at a facility owned by Indian contract research organisation GVK Biosciences P/L. The review follows the inspection by the French...

  • Up the value chain, India CRAMS in talent. Lazell, Mark // Chemical Market Reporter;2/13/2006, Vol. 269 Issue 6, p26 

    The article reflects on the advantages of India in terms of value-added contract research and manufacturing services (CRAMS). A survey conducted by Economist Intelligence Unit states that India has become a hotspot for research and development. Sanjay Reddy, CEO of GVK Bioscience company,...

  • The Science of Growth. Sharma, E. Kumar // Business Today;9/7/2008, Vol. 17 Issue 18, p64 

    The article reports on the effort of GVK Biosciences (GVK Bio) in aiming for leadership in full-service contract research organization (CRO) space in India. According to the article, the company seen as one of the leading CRO from Asia in term of bandwidth of service offerings, number of people,...

  • GVK Biosciences' Ahmedabad Clinical Pharmacology Unit Successfully Clears the USFDA Audit.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article reports the completion of the audit of the Ahmedabad Clinical Pharmacology Unit of GVK Biosciences P/L that was carried out by the U.S. Food and Drug Administration. It mentions that Bioavailability and Bioequivalence studies carried out the Ahmedabad, India-based unit were submitted...

  • Fresh Shot in the Arm: John W. Ellingboe has moved from representing a client of GVK Biosciences to working with them. Sharma, E. Kumar // Business Today;1/9/2011, Vol. 20 Issue 1, p164 

    The article offers a brief profile of John W. Ellingboe, senior vice-president of Discovery Chemistry GVK Biosciences P/L. It mentions that Ellingboe was once asked by his former employer, Wyeth Research Co., Pfizer Inc. in the U.S. to seek for companies outside the country to outsource...

  • Sequoia close to selling 20% stake in GVK Biosciences.  // FRPT- Chemical Snapshot;3/16/2014, p12 

    The article reports that venture capital fund Sequoia Capital is reportedly planning to sell its stake in GVK Group's GVK Biosciences, a biotech research and development outsourcing company. Topics discussed include the estimated 20% stake in GVK Biosciences bought by Sequoia in 2007, a brief...

  • GVK BIO sets up isotope labeling facility.  // BioSpectrum;Dec2012, Vol. 10 Issue 12, p12 

    The article reports that the Atomic Energy Regulatory Board (AERB), Government of India, has approved GVK Biosciences to carry out 3H and 14C synthesis activities.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics